Together, these results show that MDSC depletion with MC-TG enhanced the anti-tumor efficacy of adoptively transferred OT-I CD8+ T cells, suggesting that MC-TG created a therapeutic period for transferred T cells to kill tumor cells by reducing the suppressive MDSCs in the tumor microenvironment. This evidence concerns the gene CD8A and neoplasm.